These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 24835327)

  • 41. Reproducibility of Shin's method for necrotic core and calcium content in atherosclerotic coronary lesions treated with bioresorbable everolimus-eluting vascular scaffolds using volumetric intravascular ultrasound radiofrequency-based analysis.
    Shin ES; Garcia-Garcia HM; Sarno G; Thuesen L; Dudek D; Ormiston JA; Serruys PW
    Int J Cardiovasc Imaging; 2012 Jan; 28(1):43-9. PubMed ID: 21229393
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expansion in calcific lesions and overall clinical outcomes following bioresorbable scaffold implantation optimized with intravascular ultrasound.
    Kawamoto H; Ruparelia N; Latib A; Miyazaki T; Sato K; Tanaka A; Naganuma T; Sticchi A; Chieffo A; Carlino M; Montorfano M; Colombo A
    Catheter Cardiovasc Interv; 2017 Apr; 89(5):789-797. PubMed ID: 27545845
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mid- to long-term outcome of patients treated with everolimus-eluting bioresorbable vascular scaffolds: Data of the BVS registry Göttingen predominantly from ACS patients.
    Hellenkamp K; Becker A; Gabriel YD; Hasenfuß G; Hünlich M; Jacobshagen C; Schillinger W; Schroeter MR
    Int J Cardiol; 2017 May; 234():58-63. PubMed ID: 28258843
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Temporal changes of coronary artery plaque located behind the struts of the everolimus eluting bioresorbable vascular scaffold.
    Brugaletta S; Garcia-Garcia HM; Garg S; Gomez-Lara J; Diletti R; Onuma Y; van Geuns RJ; McClean D; Dudek D; Thuesen L; Chevalier B; Windecker S; Whitbourn R; Dorange C; Miquel-Hebert K; Sudhir K; Ormiston JA; Serruys PW
    Int J Cardiovasc Imaging; 2011 Jul; 27(6):859-66. PubMed ID: 20941544
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vascular healing and integration of a fully bioresorbable everolimus-eluting scaffold in a rabbit iliac arterial model.
    Vorpahl M; Nakano M; Perkins LE; Otsuka F; Jones R; Acampado E; Lane JP; Rapoza R; Kolodgie FD; Virmani R
    EuroIntervention; 2014 Nov; 10(7):833-41. PubMed ID: 25415150
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Assessment of the hemodynamic characteristics of Absorb BVS in a porcine coronary artery model.
    Tenekecioglu E; Torii R; Bourantas C; Abdelghani M; Cavalcante R; Sotomi Y; Crake T; Su S; Santoso T; Onuma Y; Serruys PW
    Int J Cardiol; 2017 Jan; 227():467-473. PubMed ID: 27839816
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical, Angiographic, Functional, and Imaging Outcomes 12 Months After Implantation of Drug-Eluting Bioresorbable Vascular Scaffolds in Acute Coronary Syndromes.
    Gori T; Schulz E; Hink U; Kress M; Weiers N; Weissner M; Jabs A; Wenzel P; Capodanno D; Münzel T
    JACC Cardiovasc Interv; 2015 May; 8(6):770-777. PubMed ID: 25999097
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Direct bioresorbable vascular scaffold implantation: Feasibility and midterm results.
    Suárez de Lezo J; Martín P; Mazuelos F; Nóvoa J; Ojeda S; Pan M; Segura J; Hernández E; Romero M; Melián F; Medina A; Suárez de Lezo J
    Catheter Cardiovasc Interv; 2016 Apr; 87(5):E173-82. PubMed ID: 26268440
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Everolimus-eluting Bioresorbable Vascular Scaffold Implantation in Real World and Complex Coronary Disease: Procedural and 30-day Outcomes at Two Australian Centres.
    Robaei D; Back LM; Ooi SY; Pitney MR; Jepson N
    Heart Lung Circ; 2015 Sep; 24(9):854-9. PubMed ID: 25778622
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vascular compliance changes of the coronary vessel wall after bioresorbable vascular scaffold implantation in the treated and adjacent segments.
    Brugaletta S; Gogas BD; Garcia-Garcia HM; Farooq V; Girasis C; Heo JH; van Geuns RJ; de Bruyne B; Dudek D; Koolen J; Smits P; Veldhof S; Rapoza R; Onuma Y; Ormiston J; Serruys PW
    Circ J; 2012; 76(7):1616-23. PubMed ID: 22531596
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A comparison of the conformability of everolimus-eluting bioresorbable vascular scaffolds to metal platform coronary stents.
    Gomez-Lara J; Garcia-Garcia HM; Onuma Y; Garg S; Regar E; De Bruyne B; Windecker S; McClean D; Thuesen L; Dudek D; Koolen J; Whitbourn R; Smits PC; Chevalier B; Dorange C; Veldhof S; Morel MA; de Vries T; Ormiston JA; Serruys PW
    JACC Cardiovasc Interv; 2010 Nov; 3(11):1190-8. PubMed ID: 21087756
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Endothelial-dependent vasomotion in a coronary segment treated by ABSORB everolimus-eluting bioresorbable vascular scaffold system is related to plaque composition at the time of bioresorption of the polymer: indirect finding of vascular reparative therapy?
    Brugaletta S; Heo JH; Garcia-Garcia HM; Farooq V; van Geuns RJ; de Bruyne B; Dudek D; Smits PC; Koolen J; McClean D; Dorange C; Veldhof S; Rapoza R; Onuma Y; Bruining N; Ormiston JA; Serruys PW
    Eur Heart J; 2012 Jun; 33(11):1325-33. PubMed ID: 22507972
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Everolimus-eluting bioresorbable vascular scaffolds implanted in coronary bifurcation lesions: Impact of polymeric wide struts on side-branch impairment.
    De Paolis M; Felix C; van Ditzhuijzen N; Fam JM; Karanasos A; de Boer S; van Mieghem NM; Daemen J; Costa F; Bergoli LC; Ligthart JM; Regar E; de Jaegere PP; Zijlstra F; van Geuns RJ; Diletti R
    Int J Cardiol; 2016 Oct; 221():656-64. PubMed ID: 27423087
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bioresorbable vascular scaffold thrombosis in a consecutive cohort of 550 patients.
    Tröbs M; Achenbach S; Röther J; Klinghammer L; Schlundt C
    Catheter Cardiovasc Interv; 2016 Nov; 88(6):872-880. PubMed ID: 27142643
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Segmental vessel wall shear stress and neointimal formation after sirolimus-eluting stent implantation: physiological insights in a porcine coronary model.
    Carter AJ; Wei W; Gibson L; Collingwood R; Tio F; Dooley J; Kopia GA
    Cardiovasc Revasc Med; 2005; 6(2):58-64. PubMed ID: 16263360
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Early experience and favorable clinical outcomes of everolimus-eluting bioresorbable scaffolds for coronary artery disease in Korea.
    Kwon O; Ahn JM; Kang DY; Kang SH; Lee PH; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Park DW; Park SJ
    Korean J Intern Med; 2018 Sep; 33(5):922-932. PubMed ID: 29108400
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bioresorbable everolimus-eluting vascular scaffold for the treatment of chronic total occlusions: CTO-ABSORB pilot study.
    Vaquerizo B; Barros A; Pujadas S; Bajo E; Estrada D; Miranda-Guardiola F; Rigla J; Jiménez M; Cinca J; Serra A
    EuroIntervention; 2015 Sep; 11(5):555-63. PubMed ID: 25499833
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Structural and Functional Evaluation of Coronary Arteries Treated With ABSORB Bioresorbable Vascular Scaffold at 5-Year Follow-Up.
    Goncalves-Ramírez LR; Amat-Santos IJ; Altisent OA; Gutiérrez H; Pérez de Prado A; Adeliño R; Gómez I; Fernández-Vázquez F; San Román A; Puri R
    Am J Cardiol; 2022 Nov; 182():1-7. PubMed ID: 36075756
    [TBL] [Abstract][Full Text] [Related]  

  • 59. First US experience following FDA approval of the ABBOTT vascular bioresorbable vascular scaffold for the treatment of coronary artery disease.
    Rizik DG; Shah MG; Burke RF
    Catheter Cardiovasc Interv; 2016 Nov; 88(6):899-901. PubMed ID: 27545489
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Procedural and clinical outcomes of the Absorb everolimus-eluting bioresorbable vascular scaffold: one-month results of the Bioresorbable vascular Scaffold Evaluated At Rotterdam Cardiology Hospitals (B-SEARCH).
    Simsek C; Magro M; Onuma Y; Boersma E; Smits P; Dorange C; Veldhof S; Regar E; Serruys PW; van Geuns RJ
    EuroIntervention; 2014 Jun; 10(2):236-40. PubMed ID: 23999210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.